Could a common liver pill speed up jaundice recovery in newborns?

NCT ID NCT07110987

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a medicine called ursodeoxycholic acid (UDCA) to standard light therapy helps clear jaundice faster in newborns. About 70 babies born at 34 weeks or later with jaundice will be randomly assigned to receive either light therapy alone or light therapy plus UDCA. The goal is to see if UDCA reduces the time needed for treatment and shortens hospital stays.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERBILIRUBINEMIA, NEONATAL INDIRECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lattakia University Hospital

    RECRUITING

    Latakia, 0000, Syria